Efficacy of an AFCN Proxy Block in Post-TKA Multimodal Pain Management
Efficacy Assessment of Supra-Sartorial Subcutaneous Infiltration (SSSI) as an Anterior Femoral Cutaneous Nerve Proxy Block in the Multimodal Pain Management After Total Knee Arthroplasty: A Randomized Controlled Trial
1 other identifier
interventional
90
1 country
1
Brief Summary
This randomized controlled trial evaluates the additive effect of Supra-Sartorial Subcutaneous Infiltration (SSSI) when performed in combination with intermittent adductor canal block (iACB) and posterior capsule local infiltration analgesia (PC-LIA) for pain management after total knee arthroplasty (TKA). SSSI, an easy-to-perform tentative proxy block to targeted anterior femoral cutaneous nerve (AFCN) block, is tested in 90 adults (45-90 years) randomized into two arms: active SSSI versus sham SSSI. Primary outcome is pain scores at rest and during movement on postoperative day 0; secondary outcomes include daily pain trajectory at rest and during movement, functional recovery scores, rescue analgesic doses over days 0-3, and quality of recovery assessment on day 4.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 10, 2025
CompletedFirst Posted
Study publicly available on registry
September 25, 2025
CompletedStudy Start
First participant enrolled
August 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2027
July 1, 2026
May 1, 2026
1 year
September 10, 2025
June 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain: VAS at rest and during movement on postoperative day 0
VAS pain scores at rest and during continuous passive motion will be taken on postoperative day 0 at 9 PM. Higher VAS pain scores indicate worse pain levels.
at 9 PM on postoperative day 0
Secondary Outcomes (6)
Pain: VAS at rest and during movement from postoperative day 1-4
From postoperative day 1 at 6 AM to postoperative day 4 at 6 AM.
Rescue ACB doses (0.3% ropivacaine, mg)
From the time discharging from post-anesthesia care unit to postoperative day 4 at 6 AM
Additional morphine doses (mg)
From the time discharging from post-anesthesia care unit to postoperative day 4 at 6 AM
Functional: TUG test
From postoperative day 1 at 6 AM to postoperative day 4 at 6 AM.
Functional: CPM maximal allowable angle
From postoperative day 0 at 9 PM to day 3 at 6 PM.
- +1 more secondary outcomes
Study Arms (2)
SSSI (active) + iACB and PC-LIA
ACTIVE COMPARATORSSSI (sham) + iACB and PC-LIA
PLACEBO COMPARATORInterventions
20 mL Ropivacaine or saline infiltrated subcutaneously from lateral to medial, superficial to vastus medialis and sartorius muscle, at femoral triangle apex using inject-as-you-advance technique, avoiding hyperechoic nerves.
A single-shot adductor canal block is first performed post-operatively with 20 mL 0.3% Ropivacaine at the level of femoral triangle apex before inserting a catheter into the canal. The following doses (20 mL each time) start at 9:00 PM on the day of surgery and are intermittently given every 12 hours until day 4.
PC-LIA consists of two 10 mL injections of 0.3% ropivacaine delivered intraoperatively to the posteromedial and posterolateral aspects of the posterior capsule before cementation. The target injection plane is the potential space between the posterior capsule and the popliteal artery.
Eligibility Criteria
You may qualify if:
- Adults aged 45-90 undergoing unilateral primary TKA for osteoarthritis.
- American Society of Anesthesiologists (ASA) physical status I-III.
- Able to provide informed consent and use NRS pain scales.
- Surgery scheduled to start before noon to standardize spinal anesthesia recovery.
You may not qualify if:
- Bilateral or revision TKA.
- Contraindications to regional anesthesia (e.g., coagulopathy, infection at injection site).
- Chronic opioid use (\>30 mg morphine equivalents/day) or preoperative NRS \>4.
- Pre-existing neurological deficits in lower extremities or AFCN-related neuropathy.
- Allergy to ropivacaine.
- Pregnancy, breastfeeding, or cognitive impairment affecting assessments.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Taipei Municipal Wanfang Hospital
Taipei, 116, Taiwan
Related Publications (6)
Yeoh SR, Chang WC, Wang KL, Tai KY, Hsu FK, Chuang CW. Supra-Sartorial Subcutaneous Infiltration (SSSI) for Anterior Femoral Cutaneous Nerve Coverage in Total Knee Arthroplasty: A Preliminary Clinical Study. Biomedicines. 2025 Sep 27;13(10):2368. doi: 10.3390/biomedicines13102368.
PMID: 41153655BACKGROUNDKampitak W, Tanavalee A, Tansatit T, Ngarmukos S, Songborassamee N, Vichainarong C. The analgesic efficacy of anterior femoral cutaneous nerve block in combination with femoral triangle block in total knee arthroplasty: a randomized controlled trial. Korean J Anesthesiol. 2021 Dec;74(6):496-505. doi: 10.4097/kja.21120. Epub 2021 Jun 29.
PMID: 34182749BACKGROUNDPivec C, Bodner G, Mayer JA, Brugger PC, Paraszti I, Moser V, Traxler H, Riegler G. Novel Demonstration of the Anterior Femoral Cutaneous Nerves using Ultrasound. Ultraschall Med. 2018 Feb 7. doi: 10.1055/s-0043-121628. Online ahead of print.
PMID: 29415312BACKGROUNDBjorn S, Nielsen TD, Jensen AE, Jessen C, Kolsen-Petersen JA, Moriggl B, Hoermann R, Bendtsen TF. The Anterior Branch of the Medial Femoral Cutaneous Nerve Innervates Cutaneous and Deep Surgical Incisions in Total Knee Arthroplasty. J Clin Med. 2024 May 31;13(11):3270. doi: 10.3390/jcm13113270.
PMID: 38892981BACKGROUNDBjorn S, Nielsen TD, Jensen AE, Jessen C, Kolsen-Petersen JA, Moriggl B, Hoermann R, Nyengaard JR, Bendtsen TF. The anterior branch of the medial femoral cutaneous nerve innervates the anterior knee: a randomized volunteer trial. Minerva Anestesiol. 2023 Jul-Aug;89(7-8):643-652. doi: 10.23736/S0375-9393.22.16910-5. Epub 2023 Feb 27.
PMID: 36852567BACKGROUNDBjorn S, Nielsen TD, Moriggl B, Hoermann R, Bendtsen TF. Anesthesia of the anterior femoral cutaneous nerves for total knee arthroplasty incision: randomized volunteer trial. Reg Anesth Pain Med. 2019 Dec 10:rapm-2019-100904. doi: 10.1136/rapm-2019-100904. Online ahead of print.
PMID: 31826920BACKGROUND
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 10, 2025
First Posted
September 25, 2025
Study Start
August 1, 2026
Primary Completion (Estimated)
August 1, 2027
Study Completion (Estimated)
September 1, 2027
Last Updated
July 1, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share